gener

Brandon May

October 7, 2021

New research provides detailed data on how cardiogenic shock teams function to reduce the risk of CS mortality.

Lauren Biscaldi

September 2, 2021

Investigators sought to find out whether short-term use of liraglutide had a cardioprotective effect in people with type 2 diabetes.

Brian Park, PharmD

May 12, 2021

The study evaluated finerenone in addition to standard of care in patients with chronic kidney disease and type 2 diabetes.

Next post in General Cardiology

FDA Expands Pfizer-BioNTech COVID-19 Vaccine EUA to Include Adolescents